LogicBio Therapeutics, Inc. ( LOGC) - Stock Earnings
Stock symbol LOGC is outdated, potentially delisted? Maybe it is available on other exchange?
LOGC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
LOGC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q4 | -9.1 million USD | 2.0 million USD |
| 2022Q1 | -6.7 million USD | 2.8 million USD |
| 2022Q2 | -5.0 million USD | 3.2 million USD |
LOGC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2019 | -40.1 million USD | 0 USD |
| 2020 | -32.6 million USD | 3.5 million USD |
| 2021 | -40.0 million USD | 5.4 million USD |
LOGC
Price: $2.07
52 week price:
Earnings Per Share: -0.88 USD
P/E Ratio: -3.94
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 81270
Market Capitalization: 68.2 million